The Mach7 Technologies Ltd (ASX: M7T) share price is soaring today after the company announced an amended contract with Adventist Health.
The post Here’s why the Mach7 (ASX:M7T) share price just reached a multi-year high appeared first on The Motley Fool Australia. –
During morning trade, the Mach7 share price stormed higher to $1.47, representing a new, multi-year high. At the time of writing, Mach7 shares have slightly pulled back to $1.45, up 9.85%. In comparison, the All Ordinaries Index (ASX: XAO) is marginally higher to 7,097 points, up 0.3%.
What’s driving the Mach7 share price?
The Mach7 share price is on the move after the company reported it has expanded its relationship with Adventist Health.
According to the release, Mach7 will provide Adventist Health the licence for its Mach7 Picture Archive Communication System (PACS) solution. This includes the Mach7 Enterprise Imaging Platform, eUnity Diagnostic Viewer, Mach7 Universal Worklist, Mach7 QC Module, and Mach7 Clinical Portal.
Terms of the deal
Under the agreement, the software licence will be rolled out in stages as per Adventist Health’s individual hospital directions. Mach7 is anticipating that 3 of the 22 hospitals will place an order within the current quarter, reflecting immediate short-term revenue generation.
The remaining orders are mostly expected to be completed by the end of the 2021 calendar year.
The contract is worth $7.9 million, and includes migration services as well as support and maintenance for 5 years.
Quick take on Adventist Health
Adventist Health is a multinational, non-profit corporation that services over 80 communities across the West Coast of the United States, and in Hawaii. The organisation provides care in hospitals, clinics, home care agencies, hospice agencies and joint-venture retirement centres.
Mach7 CEO Mr Mike Lampron welcomed the extended partnership, saying:
I am delighted to partner with Adventist for their PACS replacement project. The collaborative partnership we have established with Adventist Health has allowed us to help them expand their enterprise imaging growth strategy. I am confident Mach7’s full Enterprise PACS solution will provide a flexible and scalable foundation that meets the needs of radiologists across their health network.
Mach7 share price snapshot
The Mach7 share price has travelled higher over the last 12 months, gaining almost 90%.
Its shares reached a 52-week low of 37 cents in March, before rising to a multi-year high of $1.47 today.
Based on the current Mach7 share price, the company commands a market capitalisation of roughly $340 million.
Where to invest $1,000 right now
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.
*Returns as of June 30th
- Why IDP Education, Lake Resources, Mach7, & Tyro shares are shooting higher
- Why the Mach7 (ASX:M7T) share price is surging 8% higher today
- 2 fantastic ASX healthcare shares to buy
- Fundie names 5 ASX shares with good growth prospects
- Wilson Asset Management thinks these 2 small cap ASX shares are a buy
Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and recommends MACH7 FPO. The Motley Fool Australia has recommended MACH7 FPO. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.